Medtronic PLC (MDT) debt
What Medtronic owes, when it comes due, and what it costs to carry, from the balances and cash flows the company reports to the U.S. Securities and Exchange Commission.
At a glance
| Metric | Jul 2026 | Jul 2025 | Change |
|---|---|---|---|
| Total debt | $28.15B | $28.61B | −$456M |
| Due within a year | $2.54B | $2.43B | +$106M |
| Long-term debt | $25.62B | $26.18B | −$562M |
| Cash and equivalents | $1.69B | $1.27B | +$418M |
| Net debt | $26.46B | $27.34B | −$874M |
Total debt is the sum of the debt lines the company reports at that date (long-term, current and short-term borrowings), not a figure the company reports as a total.
Debt over time
| Balance date | Total debt | Due within a year | Long-term debt | Cash |
|---|---|---|---|---|
| Jul 2026 | $28.15B† | $2.54B | $25.62B | $1.69B |
| Apr 2026 | $28.13B | $1.79B | $26.17B | $1.95B |
| Jan 2026 | $28.07B† | $191M | $27.88B | $1.15B |
| Oct 2025 | $29.10B† | $1.42B | $27.68B | $1.28B |
| Jul 2025 | $28.61B† | $2.43B | $26.18B | $1.27B |
| Apr 2025 | $28.69B | $2.87B | $25.64B | $2.22B |
| Jan 2025 | $26.61B† | $2.62B | $23.98B | $1.24B |
| Oct 2024 | $28.33B† | $3.72B | $24.61B | $1.39B |
| Jul 2024 | $27.86B† | $1.55B | $26.31B | $1.31B |
| Apr 2024 | $25.19B | $1.09B | $23.93B | $1.28B |
| Jan 2024 | $25.18B† | $1.03B | $24.15B | $1.62B |
| Oct 2023 | $25.08B† | $1.34B | $23.74B | $1.31B |
† Sum of the debt lines the company reports at that date, not a reported total.
When it comes due
Principal due by year as of April 24, 2026.
| Due | Principal | Share of total |
|---|---|---|
| Within 1 year | $1.79B | 6.4% |
| Year 2 | $1.01B | 3.6% |
| Year 3 | $2.35B | 8.4% |
| Year 4 | $1.00B | 3.6% |
| Year 5 | $2.06B | 7.3% |
| After year 5 | $19.92B | 70.8% |
| Total | $28.13B | 100% |
Interest cost and borrowing
| Fiscal year | Interest expense | Borrowed | Repaid |
|---|---|---|---|
| FY Apr 2026 | $715M | $1.75B | $2.93B |
| FY Apr 2025 | $729M | $3.21B | $0 |
| FY Apr 2024 | $719M | $0 | $0 |
| FY Apr 2023 | $636M | $5.41B | $6.01B |
| FY Apr 2022 | $553M | $0 | $1M |
* Fiscal fourth quarter computed from the annual filing minus the three reported quarters.
About these figures
These are the balances Medtronic reports in its SEC filings as of each balance-sheet date, and the interest, borrowing and repayments it reports for each period. This page does not show market prices or yields of the company's bonds. "Long-term debt" is the line as the company tags it in its filings and may or may not include the portion due within a year.
All figures from company filings with the SEC.